Related pages Cancer Drug Information 1 Approval Process for New Cancer Treatments 2 Access to Investigational Drugs 3

This page contains brief information about nelarabine and a collection of links to more information about the use of this drug and ongoing clinical trials.

US Brand Name(s):		Arranon
FDA Approved:		Yes

Nelarabine is approved by the Food and Drug Administration (FDA) to treat T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in patients whose cancer has not gotten better with treatment or has recurred (come back) after earlier chemotherapy.

FDA Approval for Nelarabine ⁴ - Information from the FDA about the approval of this drug and the clinical trials that led to the approval.

Definition from the NCI Drug Dictionary ⁵ - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Nelarabine ⁶ - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials for Nelarabine ⁷ - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Glossary Terms

A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.

Treatment with drugs that kill cancer cells.

An agency in the U.S. federal government whose mission is to protect public health by making sure that food, cosmetics, and nutritional supplements are safe to use and truthfully labeled. The Food and Drug Administration also makes sure that drugs, medical devices, and equipment are safe and effective, and that blood for transfusions and transplant tissue are safe. Also called FDA.

Cancer that has recurred (come back), usually after a period of time during which the cancer could not be detected. The cancer may come back to the same place as the original (primary) tumor or to another place in the body. Also called recurrence.

An aggressive (fast-growing) type of leukemia (blood cancer) in which too many T-cell lymphoblasts (immature white blood cells) are found in the bone marrow and blood. Also called precursor T-lymphoblastic leukemia and T-cell acute lymphocytic leukemia.

A type of non-Hodgkin lymphoma in which too many T-cell lymphoblasts (immature white blood cells) are found in the lymph nodes and spleen. It is most common in young men. Also called precursor T-lymphoblastic lymphoma.